Diet and Prevention
"Mediterranean Dietary Pattern in a Randomized Trial: Prolonged Survival and Possible Reduced Cancer Rate."
Published in Cancer Weekly, August 10th, 1998
According to the authors' abstract of an article published in Archives of Internal Medicine, "Background: The Mediterranean dietary pattern is thought to reduce the risk of cancer in addition to being cardioprotective. However, no trial has been conducted so far to prove this belief. Methods: We compared overall survival and newly diagnosed cancer rate among 605 patients with coronary heart disease randomized in the Lyon Diet Heart Study and following either a cardioprotective Mediterranean-type diet or a control diet close to the step 1 American Heart Association prudent diet. Results: During a follow-up of 4 years, there were a total of 38 deaths (24 in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-08-10)
More Articles from Cancer Weekly
- Gene Transfer (Hematopoietic Cells)
Retroviral Transduction Sustains Gene Expression In Progeny Cells - Bone Marrow Transplantation
Clonal Hematopoiesis Predicts Transplant-Linked Leukemia - Cancer Hormone Therapy
Novel Liver Steroid Slows Angiogenesis - Cancer Immunotherapy
Adoptive Immunotherapy Slows Some Tumor Growth - Cancer Immunotherapy
Research Provides New Information about IL-12's Role in Angiogenesis - Cancer Vaccines
Melanoma DNA Vaccine Trial Initiated - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
